Ms. Sun serves as an executive board member of Hansoh Pharmaceutical Group Company Limited (Hong Kong Stock Exchange Ticker: 3692). Ms. Sun is in charge of Hansoh’s research, business development, and capital market department. Prior to joining Hansoh, Ms. Sun worked in healthcare investment management and industry research. She has a bachelor’s degree in biomedical sciences from Trinity College, University of Cambridge.
